screen of over 500 sdRNAi sequences. Regression analysis was used to establish a correlation between the frequency of occurrence of specific nucleotides and modification at any specific position in the sdRNAi duplex and its functionality in the gene suppression assay.
The best 10 sequences with the highest score were selected for each gene. Target sites were located in the open reading frame (ORF) and untranslated regions. Chemically modified oligonucleotides were synthetized as separate strands by TriLink sdRNAi was prepared by hybridization and analyzed in native TBE electrophoresis to ensure duplex formation (>90%)
Selection of functional sdRNAi
Luciferase reporter plasmids were constructed by inserting Panx1 or Casp4 targeted regions into psiCheck2 plasmids (Promega, C8021) following Renilla luciferase sequences. A previously validated MAP4K4 sdRNAi sequence was inserted into each construct as a positive control. The plasmids also contain a Firefly luciferase sequence under a separate promoter for cell number variability normalization. The obtained clones were verified by sequencing (Genewiz, South Plainfield, NJ, USA). Selected clones were amplified and palsmids were purified using a Plasmid Midi-prep kit (Macherey Nagel, 740412; Bethlehem, PA, USA). (11) sdRNAi designed using the proprietary algorithm in Advirna, LLC. The best ten lead candidates with highest scores predicted to silence mRNA expression were selected for each gene to test in cell culture and in vivo.
